A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus
- 1 May 1991
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 9 (2) , 207-208
- https://doi.org/10.1007/bf00175091
Abstract
Based upon the activity observed in this trial, there does not appear to be a significant role for AZQ as a salvage agent for leiomyosarcoma of the uterus at the dose and schedule tested.Keywords
This publication has 0 references indexed in Scilit: